| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CFO And Treasurer
2 companies
Krognes Steve E. is a Director at Denali Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sale+OE | 1,448 | $74.68 | $108,134.54 | -5.2% | |
| Jan 15, 2021 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sell | 50,000 | $71.45 | $3,572,556.34 | -1.3% | |
| Mar 30, 2020 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sell | 1,428 | $19.48 | $27,817.44 | -0.1% |